Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist proven effective for type 2 diabetes and chronic weight management, while Lipo C refers to unapproved compounded lipotropic injections containing methionine, inositol, choline, and vitamin B12
Family run, its tucked away and a favourite of many
Proposed use: Ulcerative colitis Proposed forms: Oral capsules, nasal spray, injections, transdermal cream, rectal suppository Proposed use: Wound healing Proposed forms: Subcutaneous or intramuscular injection SECRET TO WEIGHT LOSS MAY BE HIDING IN YOUR GUT, NEW STUDY SUGGESTS Proposed use: Wound healing and inflammatory condition Proposed forms: Cream and gel Proposed use: Obesity and osteoporosis Proposed forms: Subcutaneous injection Proposed use: Cerebral ischemia (shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (chronic pain condition in the face) Proposed form: Intranasal spray, subcutaneous injection CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER Proposed use: Opioid withdrawal, chronic insomnia, narcolepsy Proposed form: Subcutaneous injection Proposed use: Insomnia Proposed form: Subcutaneous injection Performance medicine and peptide expert Dr
TL;DR: For gut fixes and subtle recovery, oral's your jam
Its ability to remember patient history allows for highly personalized care, making it an excellent tool for those navigating the complexities of combination therapies like cagrlintide and tirzepatide